Cannabis Bioscience International Holdings (CBIH) Cash from Financing Activities (2022 - 2025)
Historic Cash from Financing Activities for Cannabis Bioscience International Holdings (CBIH) over the last 6 years, with Q2 2025 value amounting to $156716.0.
- Cannabis Bioscience International Holdings' Cash from Financing Activities fell 1013.99% to $156716.0 in Q2 2025 from the same period last year, while for May 2025 it was $341824.0, marking a year-over-year decrease of 2746.04%. This contributed to the annual value of $341824.0 for FY2025, which is 2746.04% down from last year.
- Per Cannabis Bioscience International Holdings' latest filing, its Cash from Financing Activities stood at $156716.0 for Q2 2025, which was down 1013.99% from $82358.0 recorded in Q1 2025.
- Over the past 5 years, Cannabis Bioscience International Holdings' Cash from Financing Activities peaked at $840661.0 during Q4 2022, and registered a low of $9534.0 during Q1 2024.
- Moreover, its 4-year median value for Cash from Financing Activities was $156716.0 (2025), whereas its average is $184323.9.
- In the last 5 years, Cannabis Bioscience International Holdings' Cash from Financing Activities crashed by 9529.75% in 2024 and then skyrocketed by 76383.47% in 2025.
- Cannabis Bioscience International Holdings' Cash from Financing Activities (Quarter) stood at $840661.0 in 2022, then tumbled by 74.21% to $216837.0 in 2023, then crashed by 66.74% to $72123.0 in 2024, then soared by 117.29% to $156716.0 in 2025.
- Its Cash from Financing Activities stands at $156716.0 for Q2 2025, versus $82358.0 for Q1 2025 and $72123.0 for Q4 2024.